Allergy medicine is expensive because of a combination of factors: the complexity of newer biologic drugs, pharmacy supply chain markups, insurance tier placement, and massive price gaps between prescription and over-the-counter versions of the same medications. Depending on what you need, annual costs can range from under $50 for generic store-brand antihistamines to thousands of dollars for specialty treatments like immunotherapy or epinephrine injectors.
The Prescription vs. OTC Price Gap
One of the most striking reasons allergy medicine feels expensive is the enormous difference between what a drug costs as a prescription versus what it costs over the counter. A JAMA analysis comparing Medicare Part D prescription prices to OTC cash prices found staggering markups for the same active ingredients. Azelastine nasal spray, for example, cost $57.40 per spray through Medicare Part D but just $1.67 per spray as an OTC product. Olopatadine eye drops showed a similar pattern: $73.90 per milliliter through a prescription plan versus $1.82 over the counter.
Even oral antihistamines show the gap, though it’s smaller. Fexofenadine (the active ingredient in Allegra) in 180-mg tablets cost $0.38 per pill through Part D and $0.20 per pill OTC. That difference might seem minor per dose, but it adds up over a full allergy season, and it gets multiplied across the healthcare system. If you’re still filling a prescription for an antihistamine that’s available OTC, you may be paying significantly more than you need to.
How Pharmacy Middlemen Inflate Prices
Between the drug manufacturer and your pharmacy counter sits a less visible player: the pharmacy benefit manager, or PBM. These companies negotiate rebates with manufacturers in exchange for placing drugs on a health plan’s preferred list. The problem is that PBMs can actually benefit from higher list prices. A higher-priced drug generates a larger rebate, and PBMs may retain a portion of that rebate, particularly in the commercial employer insurance market.
This creates a perverse incentive. Manufacturers raise list prices knowing PBMs prefer drugs with bigger rebates. PBMs favor those higher-priced options over cheaper alternatives with low or no rebates. The result, as the Kaiser Family Foundation notes, is an inflationary effect on drug pricing that raises out-of-pocket costs for patients who pay based on the list price. If you’ve ever wondered why your copay seems high even though a cheaper version of your allergy drug exists, this system is often the reason.
Epinephrine Injectors: A Case Study in High Prices
Few allergy products have drawn as much public frustration as the EpiPen. A two-pack of brand-name EpiPens currently costs $350 to $700 at cash price. Generic alternatives have brought some relief, but not as much as you might expect. Teva’s generic epinephrine auto-injector launched at roughly $300 for a two-pack. The authorized generic for EpiPen runs $175 to $300, and the authorized generic for Adrenaclick can sometimes be found for around $175.
These prices are notable because epinephrine itself is a cheap, decades-old drug. The cost isn’t in the medication. It’s in the delivery device, the regulatory requirements for auto-injector approval, and limited market competition. For families who need to keep injectors at home, at school, and in a bag, replacing them before they expire each year turns into a significant recurring expense.
Biologic Drugs Cost More to Make
If you’ve been prescribed a biologic allergy treatment (injectable medications that target specific immune pathways), the price jump is dramatic. These drugs are manufactured using living cells rather than simple chemical synthesis, and the production process is far more demanding than making a pill.
Biologic manufacturing requires constant monitoring for microbial contamination, mechanical failures, and poor cell growth. The raw materials, specialized labor, and equipment all cost more than traditional drug production. Workers need advanced technical training. Large volumes of growth media must be processed to extract relatively small quantities of the active drug. And the regulatory environment adds another layer: any change to the manufacturing process requires expensive validation, so companies face high costs even to make incremental improvements. These production realities translate directly into higher prices at the pharmacy.
Insurance Tiers and What You Actually Pay
Your insurance plan’s formulary, the list of drugs it covers, sorts medications into tiers that determine your copay. Generic antihistamines typically land on the lowest tier with the smallest copay. Brand-name prescription allergy drugs sit on higher tiers with larger copays. Specialty biologics often land on the highest tier, where you may owe a percentage of the drug’s cost (coinsurance) rather than a flat copay.
The tier your medication falls on can vary between plans, and it doesn’t always reflect the drug’s actual cost. PBM rebate negotiations influence tier placement, so a more expensive drug with a larger rebate might get better formulary positioning than a cheaper one. If your plan moves a drug to a higher tier or drops it from coverage entirely, your costs can spike without the drug’s price having changed at all.
Immunotherapy: Long-Term Treatment, Long-Term Costs
For people whose allergies don’t respond well to daily medication, immunotherapy offers a different approach: gradually training the immune system to tolerate allergens. It works, but it’s a multi-year commitment with costs that vary wildly depending on the format and your insurance.
Sublingual immunotherapy (tablets dissolved under the tongue) ranges from $500 to $2,100 per year depending on the allergy practice and how many allergens are being treated. Traditional allergy shots vary even more dramatically based on insurance coverage. PPO plans cover between 60% and 100% of immunotherapy, with weekly copays ranging from nothing to $50. Deductibles can run anywhere from $0 to $7,000, meaning some patients face steep upfront costs before insurance kicks in at all. Medicare covers 80% of immunotherapy at a flat rate, costing the insurer about $807 per year, which leaves a meaningful out-of-pocket share for patients on fixed incomes.
What You Can Do About It
The most immediate way to lower your allergy medication costs is to check whether your prescription drug has an OTC equivalent. Many popular antihistamines and nasal sprays that were once prescription-only are now available over the counter at a fraction of the price. Store-brand versions of cetirizine, loratadine, and fexofenadine cost pennies per dose.
For medications without OTC alternatives, ask your pharmacist about authorized generics or manufacturer copay cards. Compare prices across pharmacies, since cash prices can differ substantially from one store to the next. If you’re on a biologic or specialty medication, check whether the manufacturer offers a patient assistance program. These programs frequently cover a large portion of the cost for people who qualify based on income or insurance status.
If you’re paying for epinephrine injectors, ask specifically about the authorized generic versions rather than defaulting to brand-name EpiPens. The savings can be several hundred dollars per two-pack, and the devices contain the same medication at the same dose.